LH: Higher Q3 growth and margin expansion lifted FY 2026 guidance

What happened

Labcorp reported third-quarter revenue growth of 6.9% and adjusted earnings per share growth of 14.5% from a year earlier. Its adjusted operating margin rose to 15.0%, and the company raised its 2026 guidance for revenue growth and adjusted earnings per share.

Confirmed

Global impact / market context

Higher revenue and a wider adjusted operating margin mean Labcorp keeps more profit from each sale, which lifted adjusted earnings per share. The raised 2026 guidance signals management expects the improvement to continue, giving investors a stronger earnings outlook for the diagnostics business.

Analyst inference

The results suggest steady demand for diagnostic testing plus cost control are supporting profit per sale. Acquisitions and specialty testing launches broaden what Labcorp can offer, which can add revenue and help offset pressure in routine testing, shaping how investors judge its growth outlook.

Analyst inference

What to watch

1. Labcorp raised its 2026 guidance for revenue growth and adjusted earnings per share after third-quarter adjusted operating margin expanded to 15.0%, so watch whether later results stay consistent with that raised outlook. Confirmed
2. Investors could track revenue and adjusted operating margin in coming quarters to see whether the third-quarter improvement persists, since weaker profit per sale would challenge the raised 2026 guidance. Proposed
3. Watch how acquisitions and specialty testing launches contribute to revenue and costs, because integrating bought businesses can raise expenses and dilute profit per sale if savings and new sales fail to materialize. Analyst inference

Evidence

• Original source link unavailable